Eagle Pharmaceuticals, Inc. (19) | Uncategorized (6)

Recent Contracts

Announcement, dated March 28, 2022 (Filed With SEC on March 28, 2022)
Form of Director Undertaking (Filed With SEC on March 28, 2022)
Lock-up Agreement, dated March 27, 2022, by and between Eagle Pharmaceuticals, Inc. and Cosmo Pharmaceuticals N.V (Filed With SEC on March 28, 2022)
Co-Promotion Agreement, dated January 7, 2020, between the Registrant and Tyme Technologies Inc (Filed With SEC on May 11, 2020)
Description of securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 2, 2020)
Co-Promotion Agreement with Tyme Technologies, Inc., dated January 7, 2020 (Filed With SEC on March 2, 2020)